Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study | Zendy

Anita Chawla | Zendy; Filip Janků | Zendy; Jennifer J. Wheler | Zendy; Vincent A. Miller | Zendy; Jason Ryan | Zendy; Rachel Anhorn | Zendy; Zhou Zhou | Zendy; James Signorovitch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study

Author(s) -

Anita Chawla,

Filip Janků,

Jennifer J. Wheler,

Vincent A. Miller,

Jason Ryan,

Rachel Anhorn,

Zhou Zhou,

James Signorovitch

Publication year - 2018

Publication title -

jco precision oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.405

H-Index - 22

ISSN - 2473-4284

DOI - 10.1200/po.18.00074

Subject(s) - medicine , regimen , drug , oncology , single center , refractory (planetary science) , pharmacology , physics , astrobiology

Comprehensive genomic profiling (CGP) detects several classes of genomic alterations across numerous genes simultaneously and can match more patients with genomically targeted therapies than conventional molecular profiling. The current study estimated the costs of anticancer drugs and overall survival (OS) for patients who were treated with matched and unmatched therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research